LT3952858T - Navikų gydymo būdas - Google Patents

Navikų gydymo būdas

Info

Publication number
LT3952858T
LT3952858T LTEPPCT/AU2020/050360T LTAU2020050360T LT3952858T LT 3952858 T LT3952858 T LT 3952858T LT AU2020050360 T LTAU2020050360 T LT AU2020050360T LT 3952858 T LT3952858 T LT 3952858T
Authority
LT
Lithuania
Prior art keywords
treating tumours
tumours
treating
Prior art date
Application number
LTEPPCT/AU2020/050360T
Other languages
English (en)
Lithuanian (lt)
Inventor
Victoria Anne Gordon
Paul Warren Reddell
Glen Mathew BOYLE
Jason Kingsley CULLEN
Peter Gordon Parsons
Original Assignee
QBiotics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2019901280A external-priority patent/AU2019901280A0/en
Application filed by QBiotics Pty Ltd filed Critical QBiotics Pty Ltd
Publication of LT3952858T publication Critical patent/LT3952858T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/AU2020/050360T 2019-04-12 2020-04-09 Navikų gydymo būdas LT3952858T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2019901280A AU2019901280A0 (en) 2019-04-12 Method of Treatment
PCT/AU2020/050360 WO2020206504A1 (en) 2019-04-12 2020-04-09 Method of treating tumours

Publications (1)

Publication Number Publication Date
LT3952858T true LT3952858T (lt) 2026-04-10

Family

ID=72752169

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/AU2020/050360T LT3952858T (lt) 2019-04-12 2020-04-09 Navikų gydymo būdas

Country Status (26)

Country Link
US (1) US12226391B2 (https=)
EP (1) EP3952858B1 (https=)
JP (2) JP2022528915A (https=)
KR (1) KR20210152531A (https=)
CN (1) CN113924091A (https=)
AU (1) AU2020256847B2 (https=)
BR (1) BR112021020253A2 (https=)
CA (1) CA3136216C (https=)
DK (1) DK3952858T3 (https=)
EA (1) EA202192757A1 (https=)
ES (1) ES3063750T3 (https=)
FI (1) FI3952858T3 (https=)
HR (1) HRP20260232T1 (https=)
IL (1) IL287210B2 (https=)
LT (1) LT3952858T (https=)
MX (1) MX2021012449A (https=)
MY (1) MY208979A (https=)
PL (1) PL3952858T3 (https=)
PT (1) PT3952858T (https=)
RS (1) RS67777B1 (https=)
SG (1) SG11202110599RA (https=)
SI (1) SI3952858T1 (https=)
SM (1) SMT202600066T1 (https=)
UA (1) UA129840C2 (https=)
WO (1) WO2020206504A1 (https=)
ZA (1) ZA202108677B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ597019A (en) * 2005-12-23 2013-11-29 Qbiotics Ltd Tiglien-3-one derivatives
JP7013753B2 (ja) * 2017-09-15 2022-02-01 株式会社三洋物産 遊技機
IL289072B2 (en) 2019-06-19 2025-06-01 QBiotics Pty Ltd Biofilm disruption
JP2024546296A (ja) * 2021-12-21 2024-12-19 キューバイオティクス プロプライアタリー リミティド 結晶性中間体
CN120569368A (zh) * 2022-12-21 2025-08-29 Q生物股份有限公司 晶型及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ597019A (en) * 2005-12-23 2013-11-29 Qbiotics Ltd Tiglien-3-one derivatives
UA118670C2 (uk) * 2013-04-18 2019-02-25 К'Юбайотікс Лімітед Способи та композиції для загоєння ран
JP2019523303A (ja) * 2016-07-28 2019-08-22 キューバイオティクス リミティド 治療方法
CN110461324A (zh) 2017-03-23 2019-11-15 Q生物股份有限公司 用于治疗或预防肿瘤的联合疗法

Also Published As

Publication number Publication date
US20220193023A1 (en) 2022-06-23
IL287210B2 (en) 2025-07-01
AU2020256847A1 (en) 2021-11-11
PT3952858T (pt) 2026-02-26
IL287210B1 (en) 2025-03-01
SG11202110599RA (en) 2021-10-28
CA3136216A1 (en) 2020-10-15
CN113924091A (zh) 2022-01-11
EP3952858A1 (en) 2022-02-16
EP3952858B1 (en) 2025-12-17
ES3063750T3 (en) 2026-04-20
WO2020206504A1 (en) 2020-10-15
SMT202600066T1 (it) 2026-03-09
JP2022528915A (ja) 2022-06-16
ZA202108677B (en) 2026-03-25
AU2020256847B2 (en) 2025-05-15
IL287210A (en) 2021-12-01
US12226391B2 (en) 2025-02-18
DK3952858T3 (da) 2026-02-23
RS67777B1 (sr) 2026-03-31
JP2025060945A (ja) 2025-04-10
MY208979A (en) 2025-06-14
HRP20260232T1 (hr) 2026-03-27
PL3952858T3 (pl) 2026-03-30
EA202192757A1 (ru) 2022-02-11
FI3952858T3 (fi) 2026-02-18
MX2021012449A (es) 2021-11-12
CA3136216C (en) 2024-01-16
EP3952858A4 (en) 2022-05-25
KR20210152531A (ko) 2021-12-15
UA129840C2 (uk) 2025-08-20
BR112021020253A2 (pt) 2021-12-07
SI3952858T1 (sl) 2026-04-30

Similar Documents

Publication Publication Date Title
IL275663A (en) Cancer treatment methods
EP4017489A4 (en) METHODS OF TREATMENT OF KRAS-ASSOCIATED CANCER
IL287210A (en) Preparations for the treatment of tumors
IL283337A (en) Methods for treating whsc1-overexpressing cancers by inhibiting setd2
SG11202112232YA (en) Methods of treating neuropathy
IL277981A (en) Cancer treatment methods
IL284797A (en) Addiction treatment methods
IL278759A (en) A method for treating clinical depression
SG11202010793UA (en) Methods of treating cancer
ZA201908539B (en) Method of treatment of cancer
IL281600B2 (en) Cancer treatment methods
IL289811A (en) A method for treating cancer
IL290983A (en) Treatment methods
IL287250A (en) treatment method
IL288353A (en) Methods for treating cholangiocarcinoma
SG11202107017TA (en) Methods of treating cancer
GB201717945D0 (en) Method for treatment of cancer
SG11202005163PA (en) Methods of treating cancer
GB201918853D0 (en) Methods of treatment
SG11202105877YA (en) Method of treatment
SG11202102240YA (en) Methods of treating psoriasis
IL269123A (en) Methods of treating cancer
GB201820098D0 (en) Methods of cancer treatment
PL4003533T3 (pl) Sposoby leczenia raka wieloogniskowego
GB201918815D0 (en) Treatment of cancer